Evidence map›Paper›PMID 42073039›Full record

ArticleChildren (Basel, Switzerland)2026

Early Vascular Aging and Subclinical Myocardial Deformation in Children with β-Thalassemia Major: The Role of Asymmetric Dimethylarginine.

Pelin Kosger, Zeynep Canan Özdemir, Ayse Sulu, Özcan Bör, Birsen Uçar

Abstract read
In one paragraph

Article in Children (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Pelin KosgerDepartment of Pediatric Cardiology, Faculty of Medicine, Eskisehir Osmangazi University, Eskisehir 26000, Turkey.
Zeynep Canan ÖzdemirDepartment of Pediatric Hematology and Oncology, Faculty of Medicine, Eskisehir Osmangazi University, Eskisehir 26000, Turkey.
Ayse SuluDepartment of Pediatric Cardiology, Faculty of Medicine, Gaziantep University, Gaziantep 27000, Turkey.
Özcan BörDepartment of Pediatric Hematology and Oncology, Faculty of Medicine, Eskisehir Osmangazi University, Eskisehir 26000, Turkey.ORCID 0000-0002-1662-3259
Birsen UçarDepartment of Pediatric Cardiology, Faculty of Medicine, Eskisehir Osmangazi University, Eskisehir 26000, Turkey.

Funding

This study was supported by the Eskisehir Osmangazi University Scientific Research Projects Coordination Unit Project No: 202011D08
6 · The paper itself

Abstract

backgroundChildren with β-thalassemia major (β-TM) survive longer due to advances in transfusion and chelation therapy; however, cardiovascular complications have emerged as a leading cause of long-term morbidity. Chronic hemolysis, oxidative stress, and iron overload may promote early endothelial dysfunction and premature vascular aging, yet their impact on myocardial deformation in pediatric patients remains incompletely characterized.

objectivesTo evaluate subclinical myocardial dysfunction and arterial stiffness in children with β-TM and to investigate hemolysis-related changes in asymmetric dimethylarginine (ADMA) and L-arginine as biomarkers of endothelial dysfunction in relation to cardiovascular involvement.

methodsTwenty-four children with β-TM and 20 age-matched healthy controls were included. Cardiac structure and myocardial deformation were assessed by conventional echocardiography, tissue Doppler imaging, and speckle-tracking strain analysis. Arterial stiffness was evaluated using oscillometric pulse wave analysis and bilateral carotid intima-media thickness (CIMT). Serum ADMA and L-arginine levels were measured, and hemoglobin, reticulocyte count, and ferritin levels were recorded.

resultsChildren with β-thalassemia major demonstrated significantly increased arterial stiffness compared with controls, including higher PWV (4.61 ± 0.37 vs. 4.38 ± 0.31), AIx@75 (augmentation index at 75 bpm) (28.5 ± 8.34 vs. 22.8 ± 6.51), left CIMT [0.45 (0.39-0.51) vs. 0.41 (0.38-0.46)], and right CIMT [0.43 (0.39-0.54) vs. 0.40 (0.34-0.46)]. In addition, patients exhibited reduced global longitudinal strain (-19.3 ± 2.91 vs. -21.84 ± 1.91), prolonged isovolumetric relaxation time [53 (37-71) vs. 45 (37-55)], and elevated E/Em (8.44 ± 2.19 vs. 6.92 ± 1.10). ADMA levels were significantly higher in patients (0.54 ± 0.19 vs. 0.39 ± 0.22) and were positively associated with reticulocyte counts and inversely correlated with hemoglobin levels. In addition, both ADMA and ferritin levels were positively correlated with arterial stiffness indices and left ventricular filling pressures.

conclusionsChildren with β-thalassemia major exhibit features suggestive of early cardiovascular aging, including impaired myocardial deformation, diastolic involvement, and increased arterial stiffness. The observed association between ADMA levels and markers of hemolysis, vascular stiffness, and myocardial deformation highlights the potential involvement of endothelial dysfunction in premature myocardial-vascular remodeling. These findings suggest that ADMA may serve as a promising biomarker for early cardiovascular risk in pediatric β-thalassemia major; however, further longitudinal and multi-center studies are needed to confirm its clinical utility for risk stratification.

Indexed as

asymmetric dimethylarginineearly vascular agingendothelial dysfunctionmyocardial deformationβ-thalassemia major

Identifiers

PMID42073039
PMCPMC13114833

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.